A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid, -SAHA) in Metastatic Breast Cancer: A California Cancer Consortium Study

PURPOSE: The primary goal of this trial was to determine the response rate of single-agent vorinostat in patients with metastatic breast cancer. The secondary goals included assessment of time to progression, evaluation of toxicities, and overall survival. EXPERIMENTAL DESIGN: From June 2005 to Marc...

Full description

Saved in:
Bibliographic Details
Main Authors: Luu, Thehang H, Morgan, Robert J, Leong, Lucille, Lim, Dean, McNamara, Mark, Portnow, Jana, Frankel, Paul, Smith, David D., Doroshow, James H., Gandara, David R, Aparicio, Ana, Somlo, George
Format: Artigo
Language:Inglês
Published: 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3543872/
https://ncbi.nlm.nih.gov/pubmed/18981013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0122
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items